Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient [3]

Transplantation

Volumn 73, Issue 1, 2002, Pages 159-160

  Butani, Lavjay ^a   Berg, Gerre ^a   Makker, Sudesh P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FELODIPINE; FLUCONAZOLE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; AREA UNDER THE CURVE; CASE REPORT; CLINICAL FEATURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSPLASIA; KIDNEY TRANSPLANTATION; LETTER; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0037080796     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200201150-00033     Document Type: Letter

References (7)

1. Tacrolimus, a new immunosuppressant: A review of the literature
2. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
3. Effects of the antifungal agents on oxidative drug metabolism: Clinical relevance
4. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients
5. Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil
6. Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: Results of a prospective study
7. Influence of oral felodipine on serum cyclosporine concentrations